Additional findings from this analysis are scheduled to be presented at Heart Rhythm 2021.

Declining elective PCI rates, a shift toward the outpatient setting and changes in the initial management of stable ischemic heart disease all appear to be responsible for the drop.

Physicians and patients may want to consider selecting ARBs instead of ACE inhibitors as an initial treatment for hypertension, based on a new analysis in Hypertension.

The authors tracked data from stroke patients, and healthy controls, between the ages of 15 and 49 years old. 

New two-year findings, presented at TVT 2021, suggest that the Watchman FLX device is a safe alternative to long-term oral anticoagulation therapy.

According to this new analysis, the risk of pregnancy-related complications increases incrementally with the number of cardiovascular risk factors present before the pregnancy. 

Participation in cardiac rehabilitation programs remains low, the authors wrote, but this study showed that it can make a significant impact on patient outcomes. 

Lead author John Forrest, MD, a cardiologist at Yale School of Medicine, presented the findings at TVT 2021. He noted that it felt great to finally return to in-person conferences after COVID kept people at home for so long.